Transfusion

Cover image for Vol. 47 Issue 7

July 2007

Volume 47, Issue 7

Pages 1105–1333

  1. TRANSFUSION MEDICINE ILLUSTRATED

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. CLINICAL RESEARCH FOCUS
    5. How Do I. . .?
    6. BLOOD COMPONENTS
    7. BLOOD DONORS AND BLOOD COLLECTION
    8. TRANSFUSION COMPLICATIONS
    9. CELL PHYSIOLOGY
    10. TRANSPLANTATION AND CELLULAR ENGINEERING
    11. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    12. HEMAPHERESIS
    13. PARENTAGE TESTING
    14. IMMUNOHEMATOLOGY
    15. TRANSPLANTATION AND CELLULAR ENGINEERING
    16. LETTERS TO THE EDITOR
    1. Japanese repositories (page 1105)

      Masahiro Satake

      Version of Record online: 16 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01359.x

  2. EDITORIAL

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. CLINICAL RESEARCH FOCUS
    5. How Do I. . .?
    6. BLOOD COMPONENTS
    7. BLOOD DONORS AND BLOOD COLLECTION
    8. TRANSFUSION COMPLICATIONS
    9. CELL PHYSIOLOGY
    10. TRANSPLANTATION AND CELLULAR ENGINEERING
    11. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    12. HEMAPHERESIS
    13. PARENTAGE TESTING
    14. IMMUNOHEMATOLOGY
    15. TRANSPLANTATION AND CELLULAR ENGINEERING
    16. LETTERS TO THE EDITOR
    1. Zero tolerance (pages 1106–1109)

      C. Prowse

      Version of Record online: 16 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01322.x

  3. CLINICAL RESEARCH FOCUS

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. CLINICAL RESEARCH FOCUS
    5. How Do I. . .?
    6. BLOOD COMPONENTS
    7. BLOOD DONORS AND BLOOD COLLECTION
    8. TRANSFUSION COMPLICATIONS
    9. CELL PHYSIOLOGY
    10. TRANSPLANTATION AND CELLULAR ENGINEERING
    11. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    12. HEMAPHERESIS
    13. PARENTAGE TESTING
    14. IMMUNOHEMATOLOGY
    15. TRANSPLANTATION AND CELLULAR ENGINEERING
    16. LETTERS TO THE EDITOR
    1. Observational studies: what is a cohort study? (pages 1115–1117)

      Jason Tay and Alan Tinmouth

      Version of Record online: 1 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01277.x

  4. How Do I. . .?

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. CLINICAL RESEARCH FOCUS
    5. How Do I. . .?
    6. BLOOD COMPONENTS
    7. BLOOD DONORS AND BLOOD COLLECTION
    8. TRANSFUSION COMPLICATIONS
    9. CELL PHYSIOLOGY
    10. TRANSPLANTATION AND CELLULAR ENGINEERING
    11. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    12. HEMAPHERESIS
    13. PARENTAGE TESTING
    14. IMMUNOHEMATOLOGY
    15. TRANSPLANTATION AND CELLULAR ENGINEERING
    16. LETTERS TO THE EDITOR
  5. BLOOD COMPONENTS

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. CLINICAL RESEARCH FOCUS
    5. How Do I. . .?
    6. BLOOD COMPONENTS
    7. BLOOD DONORS AND BLOOD COLLECTION
    8. TRANSFUSION COMPLICATIONS
    9. CELL PHYSIOLOGY
    10. TRANSPLANTATION AND CELLULAR ENGINEERING
    11. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    12. HEMAPHERESIS
    13. PARENTAGE TESTING
    14. IMMUNOHEMATOLOGY
    15. TRANSPLANTATION AND CELLULAR ENGINEERING
    16. LETTERS TO THE EDITOR
    1. Prevention of transfusion of platelet components contaminated with low levels of bacteria: a comparison of bacteria culture and pathogen inactivation methods (pages 1125–1133)

      Walter Nussbaumer, Doris Allersdorfer, Christoph Grabmer, Margaret Rheinschmidt, Lily Lin, Diether Schönitzer and Cornelia Lass-Flörl

      Version of Record online: 16 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01247.x

      Corrected by:

      ERRATA

      Vol. 52, Issue 8, 1842, Version of Record online: 9 AUG 2012

    2. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006) (pages 1134–1142)

      Anne F. Eder, Jean M. Kennedy, Beth A. Dy, Edward P. Notari, John W. Weiss, Chyang T. Fang, Stephen Wagner, Roger Y. Dodd, Richard J. Benjamin and American Red Cross Regional Blood Centers

      Version of Record online: 14 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01248.x

    3. Staphylococcus epidermidis forms biofilms under simulated platelet storage conditions (pages 1143–1153)

      Carey Greco, Irene Martincic, Arjeta Gusinjac, Miloslav Kalab, Ann-Fook Yang and Sandra Ramírez-Arcos

      Version of Record online: 14 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01249.x

    4. In vitro evaluation of prestorage pools consisting of mixed A and O platelet concentrates (pages 1154–1161)

      Joseph Sweeney, Nicola Kouttab, Stein Holme, Tracey Cheves and Ed Nelson

      Version of Record online: 14 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01250.x

  6. BLOOD DONORS AND BLOOD COLLECTION

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. CLINICAL RESEARCH FOCUS
    5. How Do I. . .?
    6. BLOOD COMPONENTS
    7. BLOOD DONORS AND BLOOD COLLECTION
    8. TRANSFUSION COMPLICATIONS
    9. CELL PHYSIOLOGY
    10. TRANSPLANTATION AND CELLULAR ENGINEERING
    11. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    12. HEMAPHERESIS
    13. PARENTAGE TESTING
    14. IMMUNOHEMATOLOGY
    15. TRANSPLANTATION AND CELLULAR ENGINEERING
    16. LETTERS TO THE EDITOR
    1. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen–negative) infection in the acute stage (pages 1162–1171)

      Akira Yoshikawa, Yuko Gotanda, Kiyoshi Minegishi, Rikizo Taira, Satoru Hino, Kenji Tadokoro, Hitoshi Ohnuma, Keiko Miyakawa, Katsumi Tachibana, Hideaki Mizoguchi and Japanese Red Cross NAT Screening Research Group

      Version of Record online: 19 APR 2007 | DOI: 10.1111/j.1537-2995.2007.01234.x

  7. TRANSFUSION COMPLICATIONS

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. CLINICAL RESEARCH FOCUS
    5. How Do I. . .?
    6. BLOOD COMPONENTS
    7. BLOOD DONORS AND BLOOD COLLECTION
    8. TRANSFUSION COMPLICATIONS
    9. CELL PHYSIOLOGY
    10. TRANSPLANTATION AND CELLULAR ENGINEERING
    11. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    12. HEMAPHERESIS
    13. PARENTAGE TESTING
    14. IMMUNOHEMATOLOGY
    15. TRANSPLANTATION AND CELLULAR ENGINEERING
    16. LETTERS TO THE EDITOR
    1. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program (pages 1197–1205)

      Masahiro Satake, Rikizo Taira, Hisao Yugi, Satoru Hino, Kimihiro Kanemitsu, Hisami Ikeda and Kenji Tadokoro

      Version of Record online: 1 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01276.x

    2. Bacterial infections associated with blood transfusion: experience and perspective of infectious diseases consultants (pages 1206–1211)

      Preethi L. Rao, Larry J. Strausbaugh, Laura A. Liedtke, Arjun Srinivasan, Matthew J. Kuehnert and the Infectious Diseases Society of America Emerging Infections Network

      Version of Record online: 16 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01269.x

  8. CELL PHYSIOLOGY

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. CLINICAL RESEARCH FOCUS
    5. How Do I. . .?
    6. BLOOD COMPONENTS
    7. BLOOD DONORS AND BLOOD COLLECTION
    8. TRANSFUSION COMPLICATIONS
    9. CELL PHYSIOLOGY
    10. TRANSPLANTATION AND CELLULAR ENGINEERING
    11. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    12. HEMAPHERESIS
    13. PARENTAGE TESTING
    14. IMMUNOHEMATOLOGY
    15. TRANSPLANTATION AND CELLULAR ENGINEERING
    16. LETTERS TO THE EDITOR
    1. Storage-dependent remodeling of the red blood cell membrane is associated with increased immunoglobulin G binding, lipid raft rearrangement, and caspase activation (pages 1212–1220)

      Anastasios G. Kriebardis, Marianna H. Antonelou, Konstantinos E. Stamoulis, Effrosini Economou-Petersen, Lukas H. Margaritis and Issidora S. Papassideri

      Version of Record online: 14 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01254.x

    2. Profiling of alterations in platelet proteins during storage of platelet concentrates (pages 1221–1233)

      Thomas Thiele, Leif Steil, Simon Gebhard, Christian Scharf, Elke Hammer, Matthias Brigulla, Norbert Lubenow, Kenneth J. Clemetson, Uwe Völker and Andreas Greinacher

      Version of Record online: 14 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01255.x

  9. TRANSPLANTATION AND CELLULAR ENGINEERING

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. CLINICAL RESEARCH FOCUS
    5. How Do I. . .?
    6. BLOOD COMPONENTS
    7. BLOOD DONORS AND BLOOD COLLECTION
    8. TRANSFUSION COMPLICATIONS
    9. CELL PHYSIOLOGY
    10. TRANSPLANTATION AND CELLULAR ENGINEERING
    11. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    12. HEMAPHERESIS
    13. PARENTAGE TESTING
    14. IMMUNOHEMATOLOGY
    15. TRANSPLANTATION AND CELLULAR ENGINEERING
    16. LETTERS TO THE EDITOR
    1. Automated programs for collection of mononuclear cells and progenitor cells by two separators for peripheral blood progenitor cell transplantation: comparison by a randomized crossover study (pages 1234–1240)

      Kazuhiko Ikeda, Hitoshi Ohto, Takahiro Kanno, Takashi Ogata, Hideyoshi Noji, Kazuei Ogawa and Yukio Maruyama

      Version of Record online: 14 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01256.x

    2. Short-term liquid storage of CD14+ monocytes, CD11c+, and CD123+ precursor dendritic cells produced by leukocytapheresis (pages 1241–1249)

      Erwin F. Strasser, Benjamin Keller, Martin Hendelmeier, Jürgen Ringwald, Jürgen Zingsem and Reinhold Eckstein

      Version of Record online: 14 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01257.x

    3. Mobilization, collection, and immunomagnetic selection of peripheral blood CD34 cells in recovered aplastic anemia patients (pages 1250–1253)

      Elaine M. Sloand, Elizabeth J. Read, Phillip Scheinberg, Yong Tang, Kenneth More, Susan F. Leitman, Jaroslaw Maciejewski and Neal S. Young

      Version of Record online: 14 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01258.x

  10. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. CLINICAL RESEARCH FOCUS
    5. How Do I. . .?
    6. BLOOD COMPONENTS
    7. BLOOD DONORS AND BLOOD COLLECTION
    8. TRANSFUSION COMPLICATIONS
    9. CELL PHYSIOLOGY
    10. TRANSPLANTATION AND CELLULAR ENGINEERING
    11. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    12. HEMAPHERESIS
    13. PARENTAGE TESTING
    14. IMMUNOHEMATOLOGY
    15. TRANSPLANTATION AND CELLULAR ENGINEERING
    16. LETTERS TO THE EDITOR
    1. Prolonged hemostatic ability of polyethylene glycol–modified polymerized albumin particles carrying fibrinogen γ-chain dodecapeptide (pages 1254–1262)

      Yosuke Okamura, Toshinori Fujie, Hitomi Maruyama, Makoto Handa, Yasuo Ikeda and Shinji Takeoka

      Version of Record online: 2 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01265.x

  11. HEMAPHERESIS

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. CLINICAL RESEARCH FOCUS
    5. How Do I. . .?
    6. BLOOD COMPONENTS
    7. BLOOD DONORS AND BLOOD COLLECTION
    8. TRANSFUSION COMPLICATIONS
    9. CELL PHYSIOLOGY
    10. TRANSPLANTATION AND CELLULAR ENGINEERING
    11. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    12. HEMAPHERESIS
    13. PARENTAGE TESTING
    14. IMMUNOHEMATOLOGY
    15. TRANSPLANTATION AND CELLULAR ENGINEERING
    16. LETTERS TO THE EDITOR
    1. Protein A immunoadsorption therapy for refractory, mitomycin C–associated thrombotic microangiopathy (pages 1263–1267)

      Stefan Kasper, Markus F. Neurath, Christoph Huber, Matthias Theobald and Inge Scharrer

      Version of Record online: 2 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01266.x

    2. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product (pages 1268–1275)

      Boris Calmels, Claude Lemarié, Benjamin Esterni, Caroline Malugani, Aude Charbonnier, Diane Coso, Jean-Marc Schiano de Colella, Eric Deconinck, Denis Caillot, Frédéric Viret, Patrick Ladaique, Valérie Lapierre and Christian Chabannon

      Version of Record online: 2 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01267.x

  12. PARENTAGE TESTING

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. CLINICAL RESEARCH FOCUS
    5. How Do I. . .?
    6. BLOOD COMPONENTS
    7. BLOOD DONORS AND BLOOD COLLECTION
    8. TRANSFUSION COMPLICATIONS
    9. CELL PHYSIOLOGY
    10. TRANSPLANTATION AND CELLULAR ENGINEERING
    11. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    12. HEMAPHERESIS
    13. PARENTAGE TESTING
    14. IMMUNOHEMATOLOGY
    15. TRANSPLANTATION AND CELLULAR ENGINEERING
    16. LETTERS TO THE EDITOR
    1. Genotype probabilities of pairs of individuals for X-chromosome markers (pages 1276–1280)

      Chiara Toni, Ranieri Domenici and Silvano Presciuttini

      Version of Record online: 2 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01270.x

  13. IMMUNOHEMATOLOGY

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. CLINICAL RESEARCH FOCUS
    5. How Do I. . .?
    6. BLOOD COMPONENTS
    7. BLOOD DONORS AND BLOOD COLLECTION
    8. TRANSFUSION COMPLICATIONS
    9. CELL PHYSIOLOGY
    10. TRANSPLANTATION AND CELLULAR ENGINEERING
    11. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    12. HEMAPHERESIS
    13. PARENTAGE TESTING
    14. IMMUNOHEMATOLOGY
    15. TRANSPLANTATION AND CELLULAR ENGINEERING
    16. LETTERS TO THE EDITOR
    1. Identification and quantification of fetal red blood cells in maternal blood by a dual-color flow cytometric method: evaluation of the Fetal Cell Count kit (pages 1281–1289)

      Valérie Porra, Janine Bernaud, Pierre Gueret, Pascaline Bricca, Dominique Rigal, Gilles Follea and Dominique Blanchard

      Version of Record online: 2 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01271.x

    2. HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia (pages 1296–1305)

      Cedric Ghevaert, Kate Campbell, Prachi Stafford, Paul Metcalfe, Angela Casbard, Graham A. Smith, Dave Allen, Edmund Ranasinghe, Lorna M. Williamson and Willem H. Ouwehand

      Version of Record online: 2 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01273.x

    3. Two missense mutations in the CD44 gene encode two new antigens of the Indian blood group system (pages 1306–1311)

      Joyce Poole, Louise Tilley, Nicole Warke, Frances A. Spring, Marijke A.M. Overbeeke, José A.C.M. Van Der Mark-Zoet, Norbert Ahrens, Diane Armstrong, Mark Williams and Geoff Daniels

      Version of Record online: 2 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01275.x

      Corrected by:

      CORRECTION

      Vol. 47, Issue 9, 1741, Version of Record online: 20 AUG 2007

  14. TRANSPLANTATION AND CELLULAR ENGINEERING

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. CLINICAL RESEARCH FOCUS
    5. How Do I. . .?
    6. BLOOD COMPONENTS
    7. BLOOD DONORS AND BLOOD COLLECTION
    8. TRANSFUSION COMPLICATIONS
    9. CELL PHYSIOLOGY
    10. TRANSPLANTATION AND CELLULAR ENGINEERING
    11. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    12. HEMAPHERESIS
    13. PARENTAGE TESTING
    14. IMMUNOHEMATOLOGY
    15. TRANSPLANTATION AND CELLULAR ENGINEERING
    16. LETTERS TO THE EDITOR
    1. ISBT 128 Implementation Plan for Cellular Therapy Products (pages 1312–1318)

      Paul Ashford, Pat Distler, Adrian Gee, Alan Lankester, Stella Larsson, Irene Feller, Kathy Loper, Derwood Pamphilon, Leigh Poston, Fran Rabe, Ineke Slaper-Cortenbach, Zbigniew Szczepiorkowski and Phyllis Warkentin

      Version of Record online: 16 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01390.x

    2. Standards for the Terminology and Labeling of Cellular Therapy Products (pages 1319–1327)

      Paul Ashford, Pat Distler, Adrian Gee, Alan Lankester, Stella Larsson, Irene Feller, Kathy Loper, Derwood Pamphilon, Leigh Poston, Fran Rabe, Ineke Slaper-Cortenbach, Zbigniew Szczepiorkowski and Phyllis Warkentin

      Version of Record online: 16 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01389.x

  15. LETTERS TO THE EDITOR

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. CLINICAL RESEARCH FOCUS
    5. How Do I. . .?
    6. BLOOD COMPONENTS
    7. BLOOD DONORS AND BLOOD COLLECTION
    8. TRANSFUSION COMPLICATIONS
    9. CELL PHYSIOLOGY
    10. TRANSPLANTATION AND CELLULAR ENGINEERING
    11. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    12. HEMAPHERESIS
    13. PARENTAGE TESTING
    14. IMMUNOHEMATOLOGY
    15. TRANSPLANTATION AND CELLULAR ENGINEERING
    16. LETTERS TO THE EDITOR
    1. Transfusion of red blood cells from an HIV-RNA-positive/anti-HIV-negative donor without HIV infection in the recipient (pages 1328–1329)

      Alessandro R. Zanetti, Umberto Bodini, Mario Clerici, Luisa Romanò, Elisabetta Paolini, Mara Biasin, Antonella Amendola and Claudio Velati

      Version of Record online: 16 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01298.x

    2. All formulations of hydroxyethyl starch are not the same (pages 1329–1330)

      Ronald G. Strauss

      Version of Record online: 16 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01299.x

    3. Reply (pages 1330–1331)

      J.J.A. Auwerda, S. Scheij, F.W.G. Leebeek, J.H.P. Wilson, O.P. Van Diggelen, K.H. Lam and P. Sonneveld

      Version of Record online: 16 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01300.x

    4. Contemporaneous autoantibodies and alloantibodies (pages 1332–1333)

      Douglas P. Blackall and Christine A. Wheeler

      Version of Record online: 16 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01301.x

SEARCH

SEARCH BY CITATION